CE mark approval follows the US FDA approval from December 2022. Treatment can enable qualifying patients to have their second side treated at least nine months after first side. Essential tremor is ...

MIAMI, Sept. 16, 2025 /PRNewswire/ -- Insightec, a global healthcare innovator pioneering the use of focused ultrasound to transform patient care, today announced that Lord Julian Fellowes, ...

Insightec is helping some patients avoid brain surgery by using focused ultrasound to treat essential tremor in a noninvasive manner. Frank Vinluan Insightec's Exablate Neuro includes a helmet that ...

MIAMI, July 13, 2020 /PRNewswire/ -- INSIGHTEC, a global medical technology innovator of incisionless surgery, announced today achievement of complete Medicare coverage across all 50 states for ...

HAIFA, Israel and MIAMI, July 8, 2025 /PRNewswire/ -- Insightec, a global healthcare innovator dedicated to using focused ultrasound to transform patient care, announced today that the U.S. Food and ...

Tel Aviv, Israel, June 03, 2019 (GLOBE NEWSWIRE) -- Elbit Imaging Ltd. (TASE, OTC US: EMITF) ("Elbit" or the "Company") announced today that Insightec Ltd. ("Insightec") announced today that it has ...

InSightec has announced it has received FDA approval for its ExAblate MRI guided focused ultrasound treatment of bone metastases in patients who are not candidates for or refuse to undergo radiation ...